Specifically, in the early setting, in patients with HER2-positive breast cancer undergoing preoperative chemotherapy, a higher TIL score correlates with an increased probability of achieving a pathological complete response [8, 9]. This evidence concerns the gene ERBB2 and breast carcinoma.